Are late complications  of Parkinson’s disease really late? NO

1. Stacy M, Bowron A, Guttman M et al. Identification of motor and nonmotor wearing-off in Parkinson’s disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord 2005; 20(6): 726–733. doi: 10.1002/ mds.20383.

2. Schrag A, Ben-Shlomo Y, Brown R et al. Young-onset Parkinson’s disease revisited –⁠ clinical features, natural history, and mortality. Mov Disord 1998; 13(6): 885–894. doi: 10.1002/ mds.870130605.

3. Ishihara LS, Cheesbrough A, Brayne C et al. Estimated life expectancy of Parkinson’s patients compared with the UK population. J Neurol Neurosurg Psychiatry 2007; 78(12): 1304–1309.

4. Bäckström D, Granåsen G, Domellöf ME et al. Early predictors of mortality in parkinsonism and Parkinson dis­ease: a population-based study. Neurology 2018; 91(22): e2045–e2056. doi: 10.1136/ jnnp.2006.100107.

5. Hoehn MM, Yahr MD. Parkinsonism: onset, progres­sion and mortality. Neurology 1967; 17(5): 427–442.

6. Cotzias GC, Van Woert MH, Schiffer LM. Aromatic amino acids and modification of parkinsonism. N Engl
J Med 1967; 276(7): 374–379. doi: 10.1056/ NEJM1967021 62760703.